By Stephen T. Watson
The University at Buffalo is teaming up with a major biotechnology corporation and a life-sciences startup company that grew out of research conducted at Roswell Park Cancer Institute to boost genetics-based clinical research on the Buffalo Niagara Medical Campus.
The partners announced Wednesday that Life Technologies –- which has a large media manufacturing facility on Grand Island –- is providing UB and Empire Genomics with advanced genome-sequencing equipment.
Empire Genomics will install the new equipment in lab space in its building on the edge of the medical campus, while UB has installed the technology in its New York State Center of Excellence in Bioinformatics and Life Sciences on the campus.
The sequencing technology will help UB researchers and Empire Genomics employees develop new diagnostic tests that –- eventually –- could lead to drugs targeted to individual patients, and the partnership is touted as a boon to efforts to build a life-sciences industry in Buffalo.
For more on the partnership, read Thursday's Buffalo News.